Cargando…

Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study

BACKGROUND: The UK National Institute for Health and Clinical Excellence (NICE) guidance recommends conservative management of men with ‘low-risk’ localised prostate cancer, monitoring the disease using prostate-specific antigen (PSA) kinetics and re-biopsy. However, there is little evidence of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metcalfe, C, Tilling, K, Davis, M, Lane, J A, Martin, R M, Kynaston, H, Powell, P, Neal, D E, Hamdy, F, Donovan, J L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720224/ https://www.ncbi.nlm.nih.gov/pubmed/19603015 http://dx.doi.org/10.1038/sj.bjc.6605181

Ejemplares similares

Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial
por: Wade, Julia, et al.
Publicado: (2020)

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
por: Sanghera, S., et al.
Publicado: (2020)

Establishing nurse-led active surveillance for men with localised prostate cancer: development and formative evaluation of a model of care in the ProtecT trial
por: Wade, Julia, et al.
Publicado: (2015)

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer
por: Gilbert, Rebecca, et al.
Publicado: (2018)

Men’s experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study
por: Sutton, E., et al.
Publicado: (2021)

Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)
por: Lane, Janet Athene, et al.
Publicado: (2022)

Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study
por: Catto, J W F, et al.
Publicado: (2011)

A model of the natural history of screen-detected prostate cancer
por: Metcalfe, C, et al.
Publicado: (2006)

Men’s knowledge and attitudes towards dietary prevention of a prostate cancer diagnosis: a qualitative study
por: Horwood, Jeremy P, et al.
Publicado: (2014)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
por: Rosario, Derek J, et al.
Publicado: (2012)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
por: Young, Grace J, et al.
Publicado: (2017)

Investigating the prostate specific antigen, body mass index and age relationship: is an age–BMI-adjusted PSA model clinically useful?
por: Harrison, Sean, et al.
Publicado: (2016)

Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy
por: Gilbert, Rebecca, et al.
Publicado: (2015)

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial
por: Walsh, Eleanor I., et al.
Publicado: (2016)

The importance of dietary change for men diagnosed with and at risk of prostate cancer: a multi-centre interview study with men, their partners and health professionals
por: Avery, Kerry NL, et al.
Publicado: (2014)

Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial
por: Wade, Julia, et al.
Publicado: (2015)

The ProtecT randomised trial cost-effectiveness analysis comparing active monitoring, surgery, or radiotherapy for prostate cancer
por: Noble, Sian M., et al.
Publicado: (2020)

Mortality Among Men with Advanced Prostate Cancer Excluded from the ProtecT Trial
por: Johnston, Thomas J., et al.
Publicado: (2017)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
por: Harrison, Sean, et al.
Publicado: (2020)

Long-term outcome among men with conservatively treated localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2006)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Men's help‐seeking in the first year after diagnosis of localised prostate cancer
por: Hyde, M.K., et al.
Publicado: (2016)

A randomised trial of robotic and open prostatectomy in men with localised prostate cancer
por: Gardiner, Robert A, et al.
Publicado: (2012)

The experiences of giving and receiving social support for men with localised prostate cancer and their partners
por: Nelson, Kayleigh, et al.
Publicado: (2019)

Acceptability of dietary and physical activity lifestyle modification for men following radiotherapy or radical prostatectomy for localised prostate cancer: a qualitative investigation
por: Hackshaw-McGeagh, Lucy E., et al.
Publicado: (2017)

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result
por: Macefield, R C, et al.
Publicado: (2010)

ProsCan for Men: Randomised controlled trial of a decision support intervention for men with localised prostate cancer
por: Chambers, Suzanne K, et al.
Publicado: (2008)

Do people who choose their treatment in a large randomised trial with parallel preference groups differ at baseline from those who agree to random treatment allocation? Results from the protect study
por: Mills, Nicola, et al.
Publicado: (2015)

Association of obesity with prostate cancer: a case-control study within the population-based PSA testing phase of the ProtecT study
por: Dimitropoulou, P, et al.
Publicado: (2011)

Social ecological influences on treatment decision‐making in men diagnosed with low risk, localised prostate cancer
por: McIntosh, Megan, et al.
Publicado: (2022)

A Pilot retrospective analysis of alpha-blockers on recurrence in men with localised prostate cancer treated with radiotherapy
por: Hart, Jordan, et al.
Publicado: (2020)

Current Trends in the Management of Localised Prostate Cancer
por: Sibley, G. N. A., et al.
Publicado: (1992)

Prostate cancer–Exercise and Metformin Trial (Pre-EMpT): study protocol for a feasibility factorial randomized controlled trial in men with localised or locally advanced prostate cancer
por: McGeagh, Lucy, et al.
Publicado: (2022)

Associations between an Obesity Related Genetic Variant (FTO rs9939609) and Prostate Cancer Risk
por: Lewis, Sarah J., et al.
Publicado: (2010)

Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis
por: Xiong, Tengbin, et al.
Publicado: (2014)

Growth patterns in Onychophora (velvet worms): lack of a localised posterior proliferation zone
por: Mayer, Georg, et al.
Publicado: (2010)

Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men
por: Gunnell, D, et al.
Publicado: (2003)

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
por: Donovan, Jenny L., et al.
Publicado: (2018)

Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study
por: Mazariego, Carolyn G, et al.
Publicado: (2020)

Preoperative imaging accuracy in size determination of prostate cancer in men undergoing radical prostatectomy for clinically localised disease
por: Ageeli, Wael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0j6str9abh4otr546olrnoa4oo